US-based drug discovery and development technology company VeriSIM Life the leading Artificial Intelligence -enabled, unique R and D decisions de-risker for breakthrough drug development, has acquired Spanish drug discovery company Molomics Biotech, the company said.
Molomics Biotech leverages proprietary AI technology in an effort to design more efficacious and safer therapeutics to achieve higher successes in clinical trials.
Health Catalyst Acquires Armus to Enhance Outsourced Services Offerings
Concentric Acquires Mesa Technical Associates to Expand Footprint in Northeast
UNS Acquires CyberPeak Solutions to Expand Cybersecurity Offerings
Modus Create Acquires Atlas Authority to Expand Team of Atlassian Services Providers
Alira Health Acquires RedCrow to Extend Healthcare Focussed Financing Opportunities
Easterly government Properties Acquires Colorado-Based National Archives and Records Center
ICE Global Consulting Merges with CliniStart to Expand Services in Clinical Research Contracting
Axiologic Solutions Acquires Data Intelligence Technologies to Expand IC Portfolio
Spacer Technologies Acquires WhereiPark to Monetise Existing Assets in Sharing Economy
VeriSIM Life Acquires Spanish Drug Discovery Firm Molomics Biotech
Carsharing Marketplace Getaround to Go Public via Merger with SPAC
Arklyz Acquires European Sneakers and Streetwear Seller Asphaltgold
SilverBow Resources Closes USD 71m Acquisition of Oil and Gas Firm SandPoint
Relation Insurance Services Acquires the Assets of The Wills Agency
Principal Shareholders of Avianca, Controlling Shareholder of GOL to Create Abra Group